ESR1 and breast carcinoma: In conclusion, our results suggest that MSCs and CAFs are able to trigger downregulation of IGFBP5 expression in ERα-positive breast cancer cells, such as MCF-7 cells, and, as a consequence, induce a number of changes in signaling pathway activities and gene expression (summarized in Figure 9).